2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2023 Dec 11

PMID 38078589

Affiliations

Soon will be listed here.

Abstract

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

Citing Articles

Regulation of the immune microenvironment by SUMO in diabetes mellitus.

Zhuo Y, Fu S, Qiu Y Front Immunol. 2025; 16:1506500.

PMID: 40078991 PMC: 11896877. DOI: 10.3389/fimmu.2025.1506500.

Clinical Profile and Management of Patients with Newly Diagnosed Type 2 Diabetes Mellitus in Hospital Setting.

Munoz Moreno D, Perez Lopez G, Alvarez-Sala Walther L, Rueda Camino J, Martin Vallejo J, Gonzalez Albarran O Clin Med Insights Endocrinol Diabetes. 2025; 18:11795514251323831.

PMID: 40078450 PMC: 11898092. DOI: 10.1177/11795514251323831.

Vitamin D and Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Implications-A Narrative Review.

Fuentes-Barria H, Aguilera-Eguia R, Flores-Fernandez C, Angarita-Davila L, Rojas-Gomez D, Alarcon-Rivera M Int J Mol Sci. 2025; 26(5).

PMID: 40076782 PMC: 11900948. DOI: 10.3390/ijms26052153.

Visualization of Critical Limits and Critical Values Facilitates Interpretation.

Shah A, Dohner J, Cheng K, Garcia M, Kost G Diagnostics (Basel). 2025; 15(5).

PMID: 40075851 PMC: 11899349. DOI: 10.3390/diagnostics15050604.

The Impact of SARS-CoV-2 Infection on Glucose Homeostasis in Hospitalized Patients with Pulmonary Impairment.

Parliteanu O, Balteanu M, Zaharia D, Constantinescu T, Cristea A, Dumitrache-Rujinscki S Diagnostics (Basel). 2025; 15(5).

PMID: 40075801 PMC: 11898410. DOI: 10.3390/diagnostics15050554.

References

Herold K, Bundy B, Long S, Bluestone J, DiMeglio L, Dufort M . An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med. 2019; 381(7):603-613. PMC: 6776880. DOI: 10.1056/NEJMoa1902226. View

Krischer J . The use of intermediate endpoints in the design of type 1 diabetes prevention trials. Diabetologia. 2013; 56(9):1919-24. PMC: 3743228. DOI: 10.1007/s00125-013-2960-7. View

Rubio-Cabezas O, Hattersley A, Njolstad P, Mlynarski W, Ellard S, White N . ISPAD Clinical Practice Consensus Guidelines 2014. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2014; 15 Suppl 20:47-64. DOI: 10.1111/pedi.12192. View

Hecking M, Kainz A, Werzowa J, Haidinger M, Doller D, Tura A . Glucose metabolism after renal transplantation. Diabetes Care. 2013; 36(9):2763-71. PMC: 3747896. DOI: 10.2337/dc12-2441. View

Lawrence J, Slezak J, Quesenberry C, Li X, Yu L, Rewers M . Incidence and predictors of type 1 diabetes among younger adults aged 20-45 years: The diabetes in young adults (DiYA) study. Diabetes Res Clin Pract. 2020; 171:108624. PMC: 10116767. DOI: 10.1016/j.diabres.2020.108624. View

Crowther C, Hiller J, Moss J, McPhee A, Jeffries W, Robinson J . Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005; 352(24):2477-86. DOI: 10.1056/NEJMoa042973. View

Scholtens D, Kuang A, Lowe L, Hamilton J, Lawrence J, Lebenthal Y . Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism. Diabetes Care. 2019; 42(3):381-392. PMC: 6385697. DOI: 10.2337/dc18-2021. View

Jenssen T, Hartmann A . Emerging treatments for post-transplantation diabetes mellitus. Nat Rev Nephrol. 2015; 11(8):465-77. DOI: 10.1038/nrneph.2015.59. View

Bergenstal R, Gal R, Connor C, Gubitosi-Klug R, Kruger D, Olson B . Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels. Ann Intern Med. 2017; 167(2):95-102. DOI: 10.7326/M16-2596. View

10.

Conte C, Lapeyre-Mestre M, Hanaire H, Ritz P . Diabetes Remission and Relapse After Bariatric Surgery: a Nationwide Population-Based Study. Obes Surg. 2020; 30(12):4810-4820. DOI: 10.1007/s11695-020-04924-3. View

11.

Metzger B, Lowe L, Dyer A, Trimble E, Chaovarindr U, Coustan D . Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358(19):1991-2002. DOI: 10.1056/NEJMoa0707943. View

12.

Selvin E, Rawlings A, Bergenstal R, Coresh J, Brancati F . No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes. Diabetes Care. 2013; 36(10):2995-3001. PMC: 3781554. DOI: 10.2337/dc12-2715. View

13.

Noctor E, Crowe C, Carmody L, Saunders J, Kirwan B, ODea A . Abnormal glucose tolerance post-gestational diabetes mellitus as defined by the International Association of Diabetes and Pregnancy Study Groups criteria. Eur J Endocrinol. 2016; 175(4):287-97. DOI: 10.1530/EJE-15-1260. View

14.

Landon M, Spong C, Thom E, Carpenter M, Ramin S, Casey B . A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009; 361(14):1339-48. PMC: 2804874. DOI: 10.1056/NEJMoa0902430. View

15.

Ziegler A, Rewers M, Simell O, Simell T, Lempainen J, Steck A . Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013; 309(23):2473-9. PMC: 4878912. DOI: 10.1001/jama.2013.6285. View

16.

Herman W, Taylor G, Jacobson J, Burke R, Brown M . Screening for prediabetes and type 2 diabetes in dental offices. J Public Health Dent. 2015; 75(3):175-82. PMC: 5053230. DOI: 10.1111/jphd.12082. View

17.

Steck A, Vehik K, Bonifacio E, Lernmark A, Ziegler A, Hagopian W . Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes Care. 2015; 38(5):808-13. PMC: 4407751. DOI: 10.2337/dc14-2426. View

18.

Thomas N, Lynam A, Hill A, Weedon M, Shields B, Oram R . Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes. Diabetologia. 2019; 62(7):1167-1172. PMC: 6559997. DOI: 10.1007/s00125-019-4863-8. View

19.

Boe B, Barbour L, Allshouse A, Heyborne K . Universal early pregnancy glycosylated hemoglobin A1c as an adjunct to Carpenter-Coustan screening: an observational cohort study. Am J Obstet Gynecol MFM. 2020; 1(1):24-32. DOI: 10.1016/j.ajogmf.2019.02.003. View

20.

. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009; 32(7):1327-34. PMC: 2699715. DOI: 10.2337/dc09-9033. View